pramipexole has been researched along with thiazoles in 295 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 33,179 | 2,100 | 12,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.68) | 18.7374 |
| 1990's | 100 (33.90) | 18.2507 |
| 2000's | 192 (65.08) | 29.6817 |
| 2010's | 1 (0.34) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamus, WS; Palluk, R; Schilling, JC | 1 |
| Mierau, J; Schingnitz, G | 1 |
| Albrecht, F; Asico, LD; Eisner, GM; Jose, PA; Kaneko, S; Robillard, JE | 1 |
| Furukawa, T; Kimura, H; Matsumoto, S; Nagashima, M; Yamada, K | 2 |
| Carter, AJ; Müller, RE | 1 |
| Brooks, DP; Weinstock, J | 1 |
| Furukawa, T; Matsumoto, S; Nagashima, M; Shirakawa, K; Yamada, K | 1 |
| Eisner, GM; Jose, PA; Kaneko, S | 1 |
| Domae, M; Furukawa, T; Hanabusa, Y; Matsumoto, S; Yamada, K | 1 |
| Domae, M; Furukawa, T; Matsumoto, S; Nagashima, M; Shirakawa, K; Yamada, K | 1 |
| Mierau, J; Schneider, CS | 1 |
| Bergstrom, DA; Gonzalez, AM; Huang, KX; Kreiss, DS; Sibley, DR; Walters, JR | 1 |
| Camacho-Ochoa, M; Evans, DL; Piercey, MF; Walker, EL | 1 |
| Chio, CL; Ensinger, HA; Huff, RM; Lajiness, ME; Mierau, J; Schneider, FJ | 1 |
| Ferrari, F; Giuliani, D | 6 |
| Asico, LD; Eisner, GM; Jose, PA; Yu, PY | 1 |
| Lin, MY; Walters, DE | 2 |
| Felder, RA; Kaskel, FJ; Kinoshita, S; Ohbu, K | 1 |
| Carlsson, A; Huff, RM; Kling-Petersen, T; Svensson, K; Waters, N | 1 |
| Ferrari, F; Giuliani, D; Pelloni, F | 1 |
| Cheeta, S; Lappas, S; Muscat, R; Willner, P | 1 |
| Fibiger, HC; Jakubovic, A; Robertson, GS; Tham, CS; Wilson, C | 1 |
| Gerlach, J; Peacock, L | 1 |
| Cutler, NR; Elvin, A; Friedman, J; Goetz, C; Hubble, JP; Koller, WC; Korts, D; Ranhosky, A; Sramek, JJ | 1 |
| Rabey, JM | 1 |
| Brown, D; Factor, SA; Molho, ES; Sanchez-Ramos, JR; Sheldon, C; Shulman, L; Singer, C; Weiner, WJ | 1 |
| Benkert, O; Müller-Siecheneder, F; Wetzel, H | 1 |
| Hoffmann, WE; Hyslop, DK; Piercey, MF; Smith, MW | 1 |
| Hanson, GD; Ichhpurani, N; Lau, YY; Selenka, JM; Talaat, R | 1 |
| Hanson, GD; Ichhpurani, N; Lau, YY | 1 |
| Camacho-Ochoa, M; Feldpausch, DL; Piercey, MF; Walker, EL | 1 |
| Barnas, C; Heiden, A; Kasper, S; Laakmann, G; Pfolz, H; Volz, HP; Zeit, H | 1 |
| Althaus, JS; Andrus, PK; Hall, ED; Oostveen, JA; VonVoigtlander, PF | 1 |
| Fici, GJ; Sethy, VH; VonVoigtlander, PF; Wu, H | 1 |
| Hall, ED; Oostveen, JA; Sethy, VH; Wu, H | 1 |
| Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G | 2 |
| Domino, EF; Kohno, Y; Ni, L; Sasa, M; Zhang, H | 2 |
| Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y | 1 |
| Carvey, PM; Ling, ZD; Pieri, S | 1 |
| Ichhpurani, AK; Peters, GR; Sisson, TL; Wright, CE | 1 |
| Korts, D; Lieberman, A; Ranhosky, A | 1 |
| Heins, JR | 1 |
| Caine, SB; Everitt, BJ; Koob, GF; Parsons, LH; Schwartz, JC; Sokoloff, P | 1 |
| Hoffmann, WE; Hyslop, DK; Piercey, MF | 1 |
| Bennett, JP; Friedman, JH; Shannon, KM | 1 |
| Wienkers, LC; Wynalda, MA | 1 |
| Davidson, M; Levy, A; Weizer, M | 1 |
| Alldredge, BK; Aminoff, MJ; Bainbridge, JL; Dowling, GA; Gottwald, MD | 1 |
| Guttman, M | 1 |
| LeWitt, PA | 2 |
| Force, RW; Ting, RM | 1 |
| Carvey, PM; Ling, ZD; Tong, CW | 1 |
| Jantos, H; Lagos, P; Monti, JM; Ponzoni, A; Reyes-Parada, M; Scorza, C; Silveira, R | 1 |
| Burger, CD; Fredrickson, PA; Kaplan, J; Lin, SC | 1 |
| Dooley, M; Markham, A | 1 |
| Bennett, JP; Cassarino, DS; Fall, CP; Smith, TS | 1 |
| Fernandez, HH; Friedman, JH | 1 |
| Yamamoto, M | 1 |
| Becker, PM; Ondo, W; Sharon, D | 1 |
| Booze, RM; Owens, J; Wallace, DR | 1 |
| Lange, KW | 1 |
| Hinds, TR; Vincenzi, FF | 1 |
| Kakimura, JI; Kitamura, Y; Kohno, Y; Kosaka, T; Matsuoka, Y; Nomura, Y; Taniguchi, T | 1 |
| Althaus, JS; Fici, GJ; VonVoigtlander, PF | 1 |
| Gmeiner, P; Niger, M; Ohnmacht, U; Thomas, C | 1 |
| Davies, R; Friedman, JH; Jacques, C | 1 |
| Minagar, A; Shulman, LM; Weiner, WJ | 1 |
| Carvey, PM; Ling, ZD; Robie, HC; Tong, CW | 1 |
| Factor, SA | 1 |
| Denesle, R; Gomez-Mancilla, B; Montplaisir, J; Nicolas, A | 1 |
| Oertel, WH; Pinter, MM; Pogarell, O | 1 |
| Blasucci, L; Goetz, CG; Stebbins, GT | 1 |
| Cummings, JL | 1 |
| Bennett, JP; Piercey, MF | 1 |
| Appel, SH; Jankovic, J; Le, W; Rowe, DB; Xie, W; Zou, L | 1 |
| Gmeiner, P; Mohr, K; Ohnmacht, U; Tränkle, C | 1 |
| Dunn, RT; Frye, MA; Goldberg, JF | 1 |
| Bala, MV; Chrischilles, EA; Greer, M; Hoerger, TJ; Holloway, RG; Rowland, C | 1 |
| Fahn, S; Frucht, S; Gordon, MF; Greene, PE; Rogers, JD | 1 |
| Galiano, ML; Grandas, F | 1 |
| Gálvez-Jiménez, N; Hanson, M; Khan, T | 1 |
| Hobson, DE; Martin, WR; Pourcher, E | 1 |
| Arnold, G; Kupsch, A | 1 |
| Phillips, P | 1 |
| Weiner, WJ | 2 |
| Montastruc, JL; Rascol, O; Senard, JM | 1 |
| Fredman, SJ; Rosenbaum, JF | 1 |
| Lorenc-Koci, E; Wolfarth, S | 1 |
| Hack, JB; Hoffman, RS; Howland, MA; Nelson, LS; Powell, G | 1 |
| Olanow, CW; Roth, T; Schapira, AH | 2 |
| Hoehn, MM | 1 |
| Lledó, A; Nash, J | 1 |
| Arellano, FM; Corrigan, M | 1 |
| Arnold, G | 1 |
| Bliwise, DL; Rye, DB | 1 |
| Lam, YW | 1 |
| Appel, SH; He, Y; Jankovic, J; Le, W; Xu, J; Zou, L | 1 |
| Abramova, NN; Bennett, JP; Cassarino, DS; Halvorsen, EM; Parker, WD; Sturgill, TW; Swerdlow, RH | 1 |
| Breen, JA; DeBattista, C; Schatzberg, AF; Solvason, HB | 1 |
| Groenke, L; Mueller, D; Oechsner, M | 1 |
| Corrigan, MH; Denahan, AQ; Evans, DL; Ragual, RJ; Wright, CE | 1 |
| Ondo, W; Tan, EK | 1 |
| Carvey, PM; Chen, EY; Ling, ZD; Lipton, JW; Ma, SY; Robie, HC; Tong, CW; Vu, TQ | 1 |
| Ryan, M; Slevin, JT; Wells, A | 1 |
| Clarke C, E; Clarke J, A; Speller J, M | 2 |
| Kakimura, J; Kitamura, Y; Kohno, Y; Takata, K; Taniguchi, T | 1 |
| Fahn, S; Frucht, SJ; Greene, PE | 1 |
| Anderson, WM; Gauger, L; Hauser, RA; Zesiewicz, TA | 1 |
| Shuster, J | 1 |
| Fava, M; Ghaemi, SN; Rankin, MA; Recht, J; Rosenbaum, JF; Sachs, GS; Sambur, MR; Sporn, J | 1 |
| Cassel, W; Krüger, HP; Möller, JC; Oertel, WH; Peter, JH; Stiasny, K | 1 |
| Blasucci, L; Goetz, CG; Kujawa, K; Leurgans, S; Raman, R | 1 |
| Finkel, MF | 1 |
| Tanner, CM | 1 |
| de Yebenes, JG | 1 |
| Hubble, JP | 1 |
| Möller, JC; Oertel, WH | 2 |
| Denesle, R; Montplaisir, J; Petit, D | 1 |
| Ferger, B; Mierau, J; Teismann, P | 1 |
| Möller, JC; Oertel, WH; Stiasny, K | 1 |
| Hauser, RA; McDowell Anderson, W; Wahba, MN; Zesiewicz, TA | 1 |
| Brannan, T; Prikhojan, A; Yahr, MD | 1 |
| Appel, SH; Jankovic, J; Le, WD; Xie, W | 1 |
| Hebenstreit, E; Pinter, MM; Rutgers, AW | 1 |
| Earl-Slater, A; Walley, T | 1 |
| Sternon, J; Supiot, F; Zegers de Beyl, D | 1 |
| Cassano, GB; Dell'Osso, L; Marazziti, D; Pfanner, C; Presta, S | 1 |
| Hanna, PA; Jankovic, J; Ondo, WG; Ratkos, L | 1 |
| Agapito, C; Bhattacharya, KF; Chaudhuri, KR; Pal, S | 1 |
| Cullen, N; Lexell, J; Zafonte, RD | 1 |
| Kakimura, J; Kitamura, Y; Kohno, Y; Nomura, Y; Takata, K; Taniguchi, T | 1 |
| Moller, H | 1 |
| Ernst, ME; Weimerskirch, PR | 1 |
| Guttman, M; Houle, S; Hussey, D; Kish, S; Stewart, D; Wilson, A | 1 |
| Jankovic, J; Le, WD | 1 |
| Anderson, DW; Neavin, T; Schneider, JS; Smith, JA | 1 |
| Dziedzicka-Wasylewska, M; Kata, M; Maj, J; Margas, W; Rogói, Z | 1 |
| Ball, J | 1 |
| Montastruc, JL; Rascol, O | 1 |
| Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
| Akiskal, H; Frare, F; Perugi, G; Ruffolo, G; Toni, C | 1 |
| Etminan, M; Rochon, PA; Samii, A; Takkouche, B | 1 |
| Ostow, M | 1 |
| Biglan, KM; Holloway, RG | 1 |
| Abramova, NA; Bennett, JP; Cassarino, DS; Khan, SM; Painter, TW | 1 |
| Di Rocco, A; Tabamo, RE | 1 |
| Ferrari, F; Giuliani, D; Ottani, A | 1 |
| Adler, CH; Blasucci, L; Carvey, P; Caviness, JN; Chase, WM; Ferry, JJ; Goetz, CG; Kompoliti, K; Leibowitz, MT; Leurgans, S; Pincus, JH; Raman, R; Tan, E; Yones, LC | 1 |
| Gasser, T; Meier, D; Oertel, WH; Pogarell, O; Pollentier, S; Spieker, S; van Hilten, JJ | 1 |
| Dallocchio, C; Mazzarello, P | 1 |
| Ahlskog, JE; Maraganore, DM; Uhl, GR; Uitti, RJ | 1 |
| Schulz, GM | 1 |
| Montgomery, EB | 2 |
| Davidson, C; Ellinwood, EH; King, GR; Lee, TH; Yu, GZ | 1 |
| Anderer, P; Hauer, C; Saletu, B; Saletu, M; Saletu-Zyhlarz, G | 1 |
| Brecht, HM; Kraus, PH; Lemke, MR; Reichmann, H | 1 |
| Lehr, E | 1 |
| Gekht, AB | 1 |
| Crevenna, R; Homann, CN; Ivanic, G; Ott, E; Suppan, K; Wenzel, K | 1 |
| Schapira, AH | 2 |
| Jennings, D; Marek, K; Seibyl, J | 1 |
| Abelli, M; Bassi, A; Battistini, G; Cassano, GB; Cassano, P; Dell'Osso, L; Gemignani, A; Houck, PR; Lattanzi, L; Pini, S; Rucci, P | 1 |
| Clarke, CE; Guttman, M | 1 |
| Black, KJ; Hershey, T; Koller, JM; Mintun, MA; Perlmutter, JS; Price, JL; Videen, TO | 1 |
| Quattrone, A; Zappia, M | 1 |
| Chervin, RD; Guilleminault, C; Palombini, L; Pelayo, R | 1 |
| Reichmann, H | 1 |
| Kuhlmann, A; Müller, T; Przuntek, H | 1 |
| Richardson, JW; Silber, MH | 1 |
| Bain, PG; Findley, LJ; Jeffs, JA; Navan, P; Pearce, RK | 2 |
| Berardelli, A; De Pandis, MF; Modugno, N; Ruggieri, S; Stocchi, F; Thomas, A; Vacca, L; Valente, M | 1 |
| Bergmans, P; Booij, J; Stoof, JC; van Royen, EA; Winogrodzka, A; Wolters, EC | 1 |
| Bassi, A; Boffa, L; Brusa, L; Caramia, MD; Peppe, A; Pierantozzi, M; Ruggieri, S; Stanzione, P; Stefani, A | 1 |
| Etminan, M; Gill, S; Samii, A | 1 |
| MacMahon, DG | 1 |
| Blackman, JA; Buck, ML; Conaway, MR; Patrick, PD | 1 |
| Bankowski, BJ; Zacur, HA | 1 |
| Morrish, PK | 1 |
| Bares, M; Dostál, V; Ehler, E; Fanfrdlová, Z; Fiedler, J; Klajblová, H; Kulist'ák, P; Rektor, I; Rektorová, I; Ressner, P; Svátová, J; Urbánek, K; Velísková, J | 1 |
| Driver-Dunckley, E; Samanta, J; Stacy, M | 1 |
| Fleckenstein, AE; Hanson, GR; Rau, KS; Truong, JG | 1 |
| Aguilera, L; Alvo, M; Elgueta, L; Erazo, S; Fabres, L; Kägi, M; Miranda, M; Venegas, P | 2 |
| Menniti, FS; Ramirez, AD; Wong, SK | 1 |
| Albin, RL; Desmond, TJ; Frey, KA; Kemmerer, ES; Kilbourn, MR | 1 |
| Inzelberg, R; Nisipeanu, P; Schechtman, E | 1 |
| Barone, P | 1 |
| Bennett, JP; Gerber, RE; Pattee, GL; Post, GR | 1 |
| Brecht, MH; Köster, J; Kraus, PH; Lemke, MR; Reichmann, H | 1 |
| Hasegawa, K; Kowa, H; Kuno, S; Mizuno, Y; Origasa, H; Yamamoto, M; Yanagisawa, N | 1 |
| Corsini, GU; Maggio, R; Millan, MJ; Novi, F; Scarselli, M | 1 |
| Lu, CS; Mok, V; Shan, DE; Tsoi, TH; Wong, KS; Yang, CC | 1 |
| Finsterer, J; Gatterer, E; Stöllberger, C | 1 |
| Borwege, S; Hagner, D; Joyce, JN; Millan, MJ; Osredkar, T; PazSoldan, M; Presgraves, S; Renish, L; Replogle, M | 1 |
| Fantini, ML; Filipini, D; Gagnon, JF; Montplaisir, J | 1 |
| Girish, M; Izurieta, R; Silber, MH | 1 |
| Casetta, I; Cesnik, E; Ferini-Strambi, L; Govoni, V; Granieri, E; Manconi, M | 1 |
| Holman, AJ | 1 |
| Johnston, L; Winkelman, JW | 1 |
| Lang, AE; Razmy, A; Shapiro, CM | 1 |
| Krahn, M; Lang, A; Marras, C; Naglie, G; Tomlinson, G | 1 |
| Jankovic, J; Le, W; Pan, T | 1 |
| Chigir', IP; Fedorova, NV; Krivonos, OV | 1 |
| Fujiwara, RA; Siuciak, JA | 1 |
| Burdick, KE; Endick, CJ; Goldberg, JF | 1 |
| Linazasoro, G | 1 |
| Kohno, Y; Takeuchi, S | 1 |
| Oertel, WH; Stiasny-Kolster, K | 1 |
| Charney, DS; Denicoff, KD; Luckenbaugh, DA; Manji, HK; Payne, JL; Quiroz, JA; Singh, J; Zarate, CA | 1 |
| Alexander-Brown, B; Atassi, F; Barclay, L; Bennett, S; Berry, D; Biglan, K; Borchert, L; Brocht, A; Brown, D; Daigneault, S; DeAngelis, M; Dillon, S; Dobson, J; Evans, S; Factor, S; Fahn, S; Fontaine, D; Ford, B; Fussell, B; Hall, J; Hammerstad, J; Harrigan, M; Hodgeman, K; Holloway, RG; Hubble, J; Jankovic, J; Kamp, C; Kieburtz, K; Kurlan, R; Lang, A; LeWitt, P; Marek, K; McDermott, M; Miyasaki, J; Montgomery, A; Musch, B; O'Connell, C; Pahwa, R; Panisset, M; Pantella, C; Petsinger, G; Pfeiffer, B; Pfeiffer, R; Rainey, P; Rajput, A; Richard, K; Riley, D; Rodnitzky, R; Ross, T; Rost-Ruffner, E; Russell, DS; Seibyl, J; Shinaman, A; Shirley, T; Shoulson, I; Shults, C; Sime, E; Stacy, M; Standaert, D; Suchowersky, O; Sutherland, L; Tennis, M; Waters, C; Watts, A; Weeks, C; Weiner, W; Welsh, M; Wood, S; Wooten, F | 1 |
| Andersen, MB; Malik, P; Peacock, L | 1 |
| Antonini, A; Belgrado, E; Bergonzi, P; Cutuli, D; Mucchiut, M | 1 |
| Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
| Cassel, W; Haja, D; Körner, Y; Krüger, HP; Meindorfner, C; Möller, JC; Oertel, WH; Stiasny-Kolster, K | 1 |
| Bara-Jimenez, W; Chase, TN; Dimitrova, T; Favit, A; Mouradian, MM; Sherzai, A | 1 |
| Silber, MH | 1 |
| Borwege, S; Hagner, D; Joyce, JN; Ryoo, H; Woolsey, C | 1 |
| Borwege, S; Joyce, JN; Millan, MJ; Presgraves, SP | 1 |
| Guilleminault, C; Martinez, S | 1 |
| Battistini, G; Cassano, GB; Cassano, P; Gemignani, A; Lattanzi, L; Navari, S; Soldani, F | 1 |
| Fernández Riestra, Fde A; Martínez-Ruiz, M; Quesada Rubio, R | 1 |
| Cooper, JM; Gu, M; Iravani, MM; Irvani, M; Jenner, P; King, D; Schapira, AH | 1 |
| Bain, PG; Findley, LJ; Navan, P; Pearce, RK; Undy, MB | 1 |
| Igarashi, T; Ishiguro, N; Morikawa, M; Saito, A; Tamai, I; Yokoyama, K | 1 |
| Friedrich, MJ | 1 |
| Köster, J; Möller, JC; Oertel, WH; Pezzoli, G; Provinciali, L | 1 |
| Bloch, DA; Ciraulo, AM; Ciraulo, DA; Elkashef, A; Knapp, CM; Leiderman, DB; LoCastro, J; Montgomery, MA; Sarid-Segal, O | 1 |
| Jankovic, J; Le, W; Pan, T; Xie, W | 1 |
| Boggie, DT; Chan, H; Delattre, ML; Morreale, AP; Plowman, BK; Schaefer, MG | 1 |
| Kurlan, R | 1 |
| Althoff, R; Jacobson, J; Martineau, RJ; Singh, A | 1 |
| Ahlgren, AJ; Holi, MM; Lauerma, H; Tuisku, K; Wahlbeck, K | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Albani, F; Lombardi, C; Montagna, P; Plazzi, G; Provini, F; Vetrugno, R; Vignatelli, L | 1 |
| Bernauer, E; Finsterer, J | 1 |
| Brecht, HM; Koester, J; Kraus, PH; Lemke, MR; Reichmann, H | 1 |
| Asanuma, M; Diaz-Corrales, FJ; Miyazaki, I; Ogawa, N; Shimizu, M; Tanaka, K | 1 |
| Holman, AJ; Myers, RR | 1 |
| Ciraulo, DA; Hennen, J; Jensen, JE; Ke, Y; Knapp, C; Kwak, T; Meyer, AA; Nassar, LE; Renshaw, PF; Sarid-Segal, O; Streeter, CC | 1 |
| Gauthier, P; Jankovic, J; Manian, P; Tintner, R | 1 |
| Ginovart, N; Ko, F; McCormick, P; Seeman, P; Willeit, M | 1 |
| Ahlskog, JE; Bower, JH; Josephs, KA; Klos, KJ; Matsumoto, JY | 1 |
| Hosoya, T; Iida, R; Kobayashi, S; Kuriyama, S; Otsuka, Y; Tomita, M | 1 |
| Boeckler, F; Elsner, J; Gmeiner, P; Heinemann, FW; Hübner, H | 1 |
| Stocchi, F | 1 |
| Buerger, E; Danzeisen, R; Dorner-Ciossek, C; Gillardon, F; Hengerer, B; Klinder, K; Krzykalla, V; Kussmaul, L; Ludolph, AC; Schild, L; Schwalenstoecker, B | 1 |
| Du, F; Huang, Y; Le, W; Li, R; Li, X | 1 |
| Cosentino, FI; Ferri, R; Iero, I; Lanuzza, B; Tripodi, M | 1 |
| Dick, AW; Holloway, RG; Noyes, K | 1 |
| Ali, N; Fujita, Y; Hamano, S; Izawa, Y; Kanematsu, Y; Tamaki, T; Tsuchiya, K; Yoshizumi, M | 1 |
| Parvez, S; Sayeed, I; Schönfeld, P; Seitz, G; Siemen, D; Trieu, I; Wallesch, CW; Winkler-Stuck, K | 1 |
| Brown, LA; Doan, J; Pellis, SM; Suchowersky, O; Whishaw, IQ | 1 |
| Cooper, JM; Haddon, CO; Iravani, MM; Jenner, P; Schapira, AH | 1 |
| Bharmal, A; Lu, C; Suchowersky, O | 1 |
| Morgan, JC; Sethi, KD; Sharma, P | 1 |
| Frank, B; Gupta, S; Vincent, JL | 1 |
| Jadhav, AS; Pathare, DB; Shingare, MS | 1 |
| Molnar, MZ; Mucsi, I; Novak, M | 1 |
| Palmieri, A | 1 |
| Altamirano, L; Cools, R; D'Esposito, M | 1 |
| Duda, JE; Goveas, J; Moberg, PJ; Morales, KH; Potenza, MN; Siderowf, AD; Stern, MB; Weintraub, D | 1 |
| Chigir', IP; Fedorova, NV | 1 |
| Becker, PM; Cappola, JJ; Koester, J; Kushida, CA; Reess, J; Sethi, KD; Winkelman, JW | 1 |
| Kanzato, N; Murao, H; Nishihira, T; Takara, H | 1 |
| Ei-Fakhrany, A; Isosaki, M; Kyotani, Y; Nakayama, H; Satoh, H; Yoshizumi, M; Zhao, J | 1 |
| Jain, S; Pandey, S; Sarma, N | 1 |
49 review(s) available for pramipexole and thiazoles
| Article | Year |
|---|---|
Second generation of dopamine agonists: pros and cons.
Topics: Antiparkinson Agents; Benzothiazoles; Cabergoline; Dopamine Agonists; Drugs, Investigational; Ergolines; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 1995 |
Dopamine agonists in schizophrenia: a review.
Topics: Antipsychotic Agents; Autoreceptors; Azepines; Benzothiazoles; Dopamine Agonists; Humans; Pramipexole; Schizophrenia; Thiazoles | 1995 |
[New antipsychotic drugs].
Topics: Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Clinical Trials as Topic; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Pramipexole; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles | 1997 |
New pharmacotherapy for Parkinson's disease.
Topics: Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Humans; Indoles; Nitriles; Nitrophenols; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Thiazoles; Tolcapone | 1997 |
New options for treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Enzyme Inhibitors; Ergolines; Guidelines as Topic; Humans; Indoles; Nitriles; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone; Treatment Outcome | 1997 |
Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Disease Progression; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome | 1998 |
Do dopamine agonists provide neuroprotection?
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles | 1998 |
Clinical pharmacology of dopamine agonists in Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Ergot Alkaloids; Humans; Indoles; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles | 1998 |
Dopamine agonists.
Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome | 1999 |
D-3 receptor agonists: combined action neurologic and neuropsychiatric agents.
Topics: Animals; Benzothiazoles; Dopamine Agonists; Humans; Mental Disorders; Nervous System Diseases; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles | 1999 |
Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Motor Activity; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles | 1999 |
[Pramipexol: a new dopaminergic agonist for the treatment of Parkinson disease].
Topics: Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome | 1999 |
Ropinirole and pramipexole, the new agonists.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Binding, Competitive; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Receptors, Dopamine; Thiazoles | 1999 |
The initial treatment of Parkinson's disease should begin with levodopa.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors | 1999 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
Clinical pharmacology of dopamine agonists.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Drug Interactions; Ergolines; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
New drugs for the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Drug Synergism; Enzyme Inhibitors; Ergolines; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone | 2000 |
Waking up to sleep episodes in Parkinson's disease.
Topics: Antiparkinson Agents; Automobile Driving; Benzothiazoles; Dopamine Agents; Humans; Indoles; Narcolepsy; Parkinson Disease; Pramipexole; Risk Factors; Thiazoles | 2000 |
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles | 2000 |
Pramipexole for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dopamine Agonists; Humans; Levodopa; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles | 2000 |
["Sleep attacks" in Parkinson patients. A side effect of nonergoline dopamine agonists or a class effect of dopamine agonists?].
Topics: Accidents, Traffic; Automobile Driving; Benzothiazoles; Contraindications; Dopamine Agents; Dopamine Agonists; Germany; Humans; Indoles; Legislation, Drug; Levodopa; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
Introduction: pramipexole: a novel dopamine agonist for the treatment of Parkinson's disease.
Topics: Benzothiazoles; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
Pre-clinical studies of pramipexole: clinical relevance.
Topics: Animals; Benzothiazoles; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
Pramipexole in the treatment of advanced Parkinson's disease.
Topics: Benzothiazoles; Clinical Trials, Phase III as Topic; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
Digest of evidence ... pramipexole and Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Parkinson Disease; Pramipexole; Thiazoles; United Kingdom | 2000 |
Possible applications for dopaminergic agents following traumatic brain injury: part 2.
Topics: Amantadine; Benzophenones; Benzothiazoles; Brain Injuries; Catechols; Dopamine Agents; Humans; Indoles; Neuroprotective Agents; Nitriles; Nitrophenols; Patient Selection; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2001 |
Newer dopamine agonists in the treatment of restless legs syndrome.
Topics: Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Female; Humans; Indoles; Male; Pramipexole; Restless Legs Syndrome; Thiazoles | 2001 |
Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles | 2001 |
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Topics: Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; MEDLINE; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles | 2001 |
A review of pramipexole and its clinical utility in Parkinson's disease.
Topics: Animals; Benzothiazoles; Dopamine Agonists; Humans; Hypotension, Orthostatic; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Sleep Wake Disorders; Thiazoles; Treatment Outcome | 2002 |
The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: a review of the literature.
Topics: Antiparkinson Agents; Benzothiazoles; Cholinergic Antagonists; Dysarthria; Humans; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Speech; Speech Therapy; Thiazoles; Voice | 2002 |
Two advances in the management of Parkinson disease.
Topics: Age Factors; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dyskinesias; Electric Stimulation Therapy; Forecasting; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Stereotaxic Techniques; Thiazoles | 2002 |
DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
Topics: Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Psychomotor Disorders; Randomized Controlled Trials as Topic; Thiazoles | 2002 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Sleep attacks--facts and fiction: a critical review.
Topics: Antiparkinson Agents; Benzothiazoles; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Dopamine agonists and neuroprotection in Parkinson's disease.
Topics: Animals; Antioxidants; Benzothiazoles; Disease Models, Animal; Dopamine Agonists; Environmental Exposure; Humans; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Parkinsonian Disorders; Pramipexole; Thiazoles | 2002 |
Do dopamine agonists or levodopa modify Parkinson's disease progression?
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes | 2002 |
Dopamine agonist monotherapy in Parkinson's disease.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Neuroprotection in idiopathic Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Cell Death; Dopamine Agonists; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease: a meta-analysis.
Topics: Adverse Drug Reaction Reporting Systems; Benzothiazoles; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Assessment; Thiazoles | 2003 |
Dopamine agonist therapy for hyperprolactinemia.
Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles | 2003 |
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.
Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Clinical strategies to prevent and delay motor complications.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
[Pharmacological profiles and clinical effects of antiparkinsonian agent, pramipexole].
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles | 2004 |
Sleep attacks in patients receiving dopamine-receptor agonists.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Pramipexole; Restless Legs Syndrome; Thiazoles | 2005 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Pramipexole in the treatment of Parkinson's disease: new developments.
Topics: Antiparkinson Agents; Benzothiazoles; Depression; Expert Testimony; Humans; Parkinson Disease; Pramipexole; Product Surveillance, Postmarketing; Thiazoles; Tremor | 2005 |
Present and future drug treatment for Parkinson's disease.
Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence | 2005 |
Management of restless legs syndrome in patients on dialysis.
Topics: Amines; Anticonvulsants; Benzothiazoles; Clonazepam; Cyclohexanecarboxylic Acids; Dopamine Agents; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Failure, Chronic; Levodopa; Narcotics; Pramipexole; Renal Dialysis; Restless Legs Syndrome; Thiazoles; Uremia | 2006 |
59 trial(s) available for pramipexole and thiazoles
| Article | Year |
|---|---|
Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans.
Topics: Adult; Benzothiazoles; Blood Pressure; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Growth Hormone; Humans; Kinetics; Male; Pramipexole; Prolactin; Pulse; Random Allocation; Receptors, Dopamine; Thiazoles | 1992 |
Pramipexole in patients with early Parkinson's disease.
Topics: Adult; Benzothiazoles; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles; Time Factors | 1995 |
The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Single-Blind Method; Thiazoles | 1995 |
Pramipexole as adjunct to haloperidol in schizophrenia. Safety and efficacy.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles | 1997 |
Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Models, Statistical; Parkinson Disease; Pramipexole; Severity of Illness Index; Thiazoles | 1997 |
Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study.
Topics: Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prognosis; Thiazoles | 1997 |
Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group.
Topics: Activities of Daily Living; Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Physical Examination; Placebos; Pramipexole; Severity of Illness Index; Thiazoles | 1997 |
Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pramipexole; Quality of Life; Severity of Illness Index; Thiazoles; Treatment Outcome | 1997 |
Encouraging initial response of restless legs syndrome to pramipexole.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Surveys and Questionnaires; Thiazoles | 1998 |
Pramipexole in progressive supranuclear palsy.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Humans; Pilot Projects; Pramipexole; Supranuclear Palsy, Progressive; Thiazoles | 1999 |
Restless legs syndrome improved by pramipexole: a double-blind randomized trial.
Topics: Adult; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Syndrome; Thiazoles | 1999 |
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles | 1999 |
Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow?
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Thiazoles; Titrimetry | 1999 |
[Pramipexol: a new dopaminergic agonist for the treatment of Parkinson disease].
Topics: Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome | 1999 |
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression.
Topics: Adult; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Assessment; Pramipexole; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2000 |
Pramipexole-induced somnolence and episodes of daytime sleep.
Topics: Aged; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Narcolepsy; Parkinson Disease; Polysomnography; Pramipexole; Retrospective Studies; Thiazoles | 2000 |
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Topics: Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Dyskinesias; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Proportional Hazards Models; Quality of Life; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2000 |
Pramipexole in the treatment of restless legs syndrome: a follow-up study.
Topics: Adult; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Satisfaction; Pramipexole; Restless Legs Syndrome; Thiazoles; Treatment Outcome | 2000 |
An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome | 2000 |
Switching from pergolide to pramipexole in patients with Parkinson's disease.
Topics: Accidental Falls; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Edema; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Pramipexole; Prospective Studies; Receptors, Dopamine; Sweating; Thiazoles; Treatment Outcome | 2001 |
Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Receptors, Dopamine; Thiazoles; Tomography, Emission-Computed | 2001 |
Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series.
Topics: Adult; Aged; Benzothiazoles; Bipolar Disorder; Depressive Disorder; Dopamine Agonists; Drug Resistance; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Psychiatric Status Rating Scales; Thiazoles | 2001 |
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain; Cocaine; Disease Progression; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Degeneration; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Regression Analysis; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics.
Topics: Aged; Antiparkinson Agents; Area Under Curve; Benzothiazoles; Biological Availability; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Parkinson Disease; Postmenopause; Pramipexole; Sex Factors; Thiazoles | 2002 |
Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Resistance; Electromyography; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pramipexole; Thiazoles; Treatment Outcome; Tremor | 2002 |
Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
Topics: Adult; Aged; Benzothiazoles; Cross-Over Studies; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motor Activity; Polysomnography; Pramipexole; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Performance; Restless Legs Syndrome; Single-Blind Method; Sleep; Sleep Stages; Thiazoles | 2002 |
Pramipexole in treatment-resistant depression: a 16-week naturalistic study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Benzothiazoles; Combined Modality Therapy; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2002 |
Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Surveys and Questionnaires; Thiazoles; Tremor | 2003 |
Combination of two different dopamine agonists in the management of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome | 2002 |
Pramipexole in comparison to l-dopa: a neuropsychological study.
Topics: Aged; Analysis of Variance; Benzothiazoles; Cognition Disorders; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.
Topics: Activities of Daily Living; Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Depression; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Pergolide; Placebos; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome | 2003 |
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.
Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment.
Topics: Aged; Amyotrophic Lateral Sclerosis; Antioxidants; Benzothiazoles; Humans; Hydroxybenzoates; Middle Aged; Oxidative Stress; Patient Dropouts; Pramipexole; Thiazoles | 2003 |
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Quality of Life; Thiazoles; Time Factors; Treatment Outcome | 2003 |
Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease.
Topics: Adult; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Female; Hong Kong; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Software Design; Taiwan; Thiazoles; Treatment Outcome | 2003 |
The effects of pramipexole in REM sleep behavior disorder.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Leg; Male; Middle Aged; Movement; Polysomnography; Pramipexole; REM Sleep Behavior Disorder; Thiazoles; Treatment Outcome | 2003 |
Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor.
Topics: Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Thiazoles; Tremor | 2003 |
Pramipexole in the management of restless legs syndrome: an extended study.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Retrospective Studies; Thiazoles | 2003 |
Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Retrospective Studies; Thiazoles; Time Factors | 2004 |
Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Double-Blind Method; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Pain Measurement; Parkinson Disease; Pramipexole; Quality of Life; Thiazoles | 2004 |
[A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease].
Topics: Activities of Daily Living; Benzophenones; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitriles; Nitrophenols; Parkinson Disease; Pergolide; Pramipexole; Quality of Life; Thiazoles; Tolcapone; Treatment Outcome | 2004 |
Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
Topics: Adult; Ambulatory Care; Anticonvulsants; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Pilot Projects; Pramipexole; Thiazoles | 2004 |
Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
Topics: Aged; Analysis of Variance; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles | 2004 |
Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Levodopa; Male; Middle Aged; Polysomnography; Pramipexole; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders; Thiazoles; Treatment Outcome | 2004 |
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Nerve Growth Factors; Pilot Projects; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Valproic Acid | 2004 |
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Topics: Aged; Benzothiazoles; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Proportional Hazards Models; Quality of Life; Severity of Illness Index; Thiazoles | 2004 |
Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Pramipexole; Thiazoles | 2004 |
Pramipexole in treatment-resistant depression: an extended follow-up.
Topics: Acute Disease; Adult; Aged; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Surveys and Questionnaires; Thiazoles; Treatment Outcome | 2004 |
A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles; Tremor | 2005 |
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Demography; Depression; Disorders of Excessive Somnolence; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Parkinson Disease; Pramipexole; Severity of Illness Index; Thiazoles; Tremor | 2005 |
Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
Topics: Adolescent; Adult; Antidepressive Agents; Benzothiazoles; Cocaine-Related Disorders; Cyclohexanols; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Paroxetine; Pentoxifylline; Phosphodiesterase Inhibitors; Pramipexole; Riluzole; Selective Serotonin Reuptake Inhibitors; Thiazoles; Venlafaxine Hydrochloride | 2005 |
Actometry in measuring the symptom severity of restless legs syndrome.
Topics: Adult; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Monitoring, Ambulatory; Motor Activity; Pramipexole; Restless Legs Syndrome; Thiazoles | 2005 |
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder.
Topics: Adult; Antioxidants; Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Feeding and Eating Disorders; Female; Humans; Male; Middle Aged; Pain Measurement; Pilot Projects; Polysomnography; Pramipexole; Retrospective Studies; Sleep Wake Disorders; Thiazoles; Treatment Outcome | 2005 |
Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole.
Topics: Activities of Daily Living; Aged; Aging; Antiparkinson Agents; Benzothiazoles; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; Parkinson Disease; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Thiazoles | 2005 |
A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Topics: Adult; Analgesics, Opioid; Benzothiazoles; Disabled Persons; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Pramipexole; Thiazoles; Treatment Outcome | 2005 |
Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Antioxidants; Benzothiazoles; Cocaine-Related Disorders; Cyclohexanols; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nicotine; Pramipexole; Prefrontal Cortex; Protons; Retrospective Studies; Thiazoles; Time Factors; Venlafaxine Hydrochloride | 2005 |
Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.
Topics: Administration, Oral; Adult; Antiparkinson Agents; Benzothiazoles; Cost-Benefit Analysis; Double-Blind Method; Female; Health Expenditures; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Prospective Studies; Reproducibility of Results; Sex Factors; Thiazoles; Time Factors; Treatment Outcome | 2005 |
Motor deficits in Parkinsonian reaching: dopa-sensitivity influenced by real-world task constraint.
Topics: Activities of Daily Living; Aged; Amantadine; Antiparkinson Agents; Arm; Benzothiazoles; Biomechanical Phenomena; Carbidopa; Catechols; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Movement; Nitriles; Parkinson Disease; Pramipexole; Thiazoles | 2006 |
Efficacy and safety of pramipexole in restless legs syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antioxidants; Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Quality of Life; Restless Legs Syndrome; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome | 2006 |
189 other study(ies) available for pramipexole and thiazoles
| Article | Year |
|---|---|
Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzothiazoles; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Exploratory Behavior; Female; Haloperidol; Male; Medial Forebrain Bundle; Mice; Motor Activity; Norepinephrine; Parkinson Disease, Secondary; Pramipexole; Rats; Receptors, Dopamine D2; Rotation; Stereoisomerism; Synapses; Thiazoles | 1992 |
Ontogeny of DA1 receptor-mediated natriuresis in the rat: in vivo and in vitro correlations.
Topics: Aging; Animals; Animals, Newborn; Benzothiazoles; Blood Pressure; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; Natriuresis; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D1; Thiazoles; Time Factors | 1992 |
Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzothiazoles; Body Temperature; Dopamine Agents; Fever; Male; Pramipexole; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles | 1992 |
Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Azepines; Benzothiazoles; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Dopamine Antagonists; Extracellular Space; Homovanillic Acid; Male; Pramipexole; Rats; Rats, Inbred Strains; Sulpiride; Thiazoles | 1991 |
The pharmacology of pramipexole in the spontaneously hypertensive rat.
Topics: Animals; Benzothiazoles; Blood Pressure; Dopamine Agents; Dose-Response Relationship, Drug; Hypertension; Male; Pramipexole; Rats; Rats, Inbred SHR; Thiazoles | 1991 |
Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Azepines; Benzothiazoles; Dose-Response Relationship, Drug; Male; Pindolol; Pramipexole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Thiazoles; Yawning | 1990 |
Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzothiazoles; Dopamine Agents; Male; Pramipexole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereotyped Behavior; Thiazoles; Yawning | 1990 |
Effect of pramipexole, a dopamine-1/dopamine-2 receptor agonist, on sodium excretion and blood pressure in spontaneously hypertensive rats.
Topics: Animals; Benzothiazoles; Blood Pressure; Dopamine Agents; Hypertension; Male; Natriuresis; Pramipexole; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles | 1990 |
Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
Topics: Animals; Azepines; Benzamides; Benzothiazoles; Dopamine Antagonists; Dose-Response Relationship, Drug; Estrogen Antagonists; Hyperprolactinemia; Injections, Subcutaneous; Male; Perfusion; Pituitary Gland, Anterior; Pramipexole; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Dopamine D2; Thiazoles | 1990 |
Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.
Topics: alpha-Methyltyrosine; Animals; Azepines; Behavior, Animal; Benzothiazoles; Dopamine Agents; Male; Methyltyrosines; Piperidines; Pramipexole; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thiazoles; Yawning | 1989 |
Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine.
Topics: Animals; Benzothiazoles; Corpus Striatum; Dopamine; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Molecular Conformation; Pramipexole; Quinolines; Rats; Receptors, Dopamine; Spectrophotometry, Infrared; Stereoisomerism; Thiazoles | 1987 |
Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
Topics: Aminoquinolines; Animals; Apomorphine; Azepines; Benzothiazoles; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Imidazoles; Male; Neurons; Phenethylamines; Piperidines; Pramipexole; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship; Substantia Nigra; Tetrahydronaphthalenes; Thiazoles; Thiophenes; Transfection | 1995 |
Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist.
Topics: Animals; Autoradiography; Benzothiazoles; Binding Sites; Brain; Cloning, Molecular; Dopamine Agonists; Male; Parkinson Disease; Pramipexole; Rats; Rats, Sprague-Dawley; Schizophrenia; Tetrahydronaphthalenes; Thiazoles | 1995 |
Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
Topics: Animals; Benzothiazoles; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dopamine Agonists; Humans; Pramipexole; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Spiperone; Thiazoles | 1995 |
Sexual attraction and copulation in male rats: effects of the dopamine agonist SND 919.
Topics: Animals; Benzothiazoles; Copulation; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Pramipexole; Rats; Rats, Wistar; Sexual Behavior, Animal; Thiazoles | 1995 |
Differential regulation of renal phospholipase C isoforms by catecholamines.
Topics: Animals; Benzothiazoles; Catecholamines; Cell Fractionation; Cytosol; Dopamine Agonists; Fenoldopam; Immunoblotting; Isoenzymes; Kidney; Kidney Cortex; Membranes; Natriuresis; Norepinephrine; Phospholipases; Pramipexole; Rats; Receptors, Dopamine D1; Signal Transduction; Thiazoles | 1995 |
Effect on rat feeding behavior of two selective D2 dopamine agonists.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Benzothiazoles; Brain; Dopamine Agonists; Dose-Response Relationship, Drug; Feeding Behavior; Lisuride; Male; Maze Learning; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Social Environment; Stereotyped Behavior; Thiazoles | 1994 |
Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age.
Topics: Aging; Aminoquinolines; Animals; Apomorphine; Azepines; Behavior, Animal; Benzothiazoles; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Piperidines; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Thiazoles | 1994 |
Dopamine-1 receptors in the proximal convoluted tubule of Dahl rats: defective coupling to adenylate cyclase.
Topics: Adenylyl Cyclases; Animals; Benzothiazoles; Blood Pressure; Colforsin; Cyclic AMP; Dopamine Agonists; Female; Fenoldopam; Hypertension; Kidney Tubules, Proximal; Male; Pramipexole; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Sodium, Dietary; Thiazoles | 1995 |
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
Topics: Analysis of Variance; Animals; Apomorphine; Benzothiazoles; CHO Cells; Cricetinae; Cricetulus; Dihydroxyphenylalanine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Male; Microdialysis; Mitogens; Motor Activity; Piperidines; Pramipexole; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Thiazoles; Transfection | 1994 |
Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist.
Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Benzothiazoles; Brain Chemistry; Dioxanes; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Idazoxan; Male; Motor Activity; Penile Erection; Phenethylamines; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior; Sulpiride; Thiazoles; Yawning; Yohimbine | 1993 |
Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.
Topics: Animals; Benzothiazoles; Conditioning, Operant; Dopamine Agonists; Drinking Behavior; Eating; Male; Pramipexole; Rats; Rats, Inbred Strains; Stress, Psychological; Sucrose; Thiazoles; Weight Loss | 1994 |
The D2 autoreceptor agonists SND 919 and PD 128483 decrease stereotypy in developing rats.
Topics: Aging; Aminoquinolines; Animals; Benzothiazoles; Dopamine Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Male; Motor Activity; Pramipexole; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Thiazoles | 1994 |
Influence of idazoxan on the dopamine D2 receptor agonist-induced behavioural effects in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Azepines; Behavior, Animal; Benzothiazoles; Dioxanes; Dopamine Agents; Dose-Response Relationship, Drug; Idazoxan; Lisuride; Male; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior; Thiazoles | 1993 |
The selective D2 dopamine receptor antagonist eticlopride counteracts the ejaculatio praecox induced by the selective D2 dopamine agonist SND 919 in the rat.
Topics: Animals; Behavior, Animal; Benzothiazoles; Copulation; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ejaculation; Female; Male; Pramipexole; Rats; Receptors, Dopamine D2; Salicylamides; Sexual Behavior, Animal; Sexual Dysfunctions, Psychological; Thiazoles | 1994 |
In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
Topics: Acetylcholine; Animals; Azepines; Benzothiazoles; Corpus Striatum; Dopamine; Dopamine Agents; Ergolines; Male; Oxidopamine; Pramipexole; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine; Salicylamides; Thiazoles | 1993 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |
Differential behavioral response to dopamine D2 agonists by sexually naive, sexually active, and sexually inactive male rats.
Topics: Animals; Azepines; Benzothiazoles; Copulation; Dopamine Agonists; Dose-Response Relationship, Drug; Ejaculation; Male; Pramipexole; Rats; Receptors, Dopamine D2; Sexual Behavior, Animal; Thiazoles | 1996 |
Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Bromocriptine; CHO Cells; Cricetinae; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Substantia Nigra; Thiazoles | 1996 |
Determination of pramipexole (U-98,528) in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry.
Topics: Administration, Oral; Atmospheric Pressure; Azepines; Benzothiazoles; Calibration; Chromatography, High Pressure Liquid; Dopamine Agonists; Humans; Linear Models; Mass Spectrometry; Pramipexole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Thiazoles | 1996 |
Determination of pramipexole (U-98,528) in human plasma and urine by high-performance liquid chromatography with electrochemical and ultraviolet detection.
Topics: Azepines; Benzothiazoles; Calibration; Chromatography, High Pressure Liquid; Dopamine Agonists; Drug Stability; Electrochemistry; Humans; Linear Models; Osmolar Concentration; Pramipexole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Thiazoles; Time Factors | 1996 |
High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
Topics: Animals; Autoradiography; Benzothiazoles; Binding, Competitive; Corpus Striatum; Dopamine Agonists; In Vitro Techniques; Ligands; Male; Osmolar Concentration; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Tissue Distribution | 1996 |
Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.
Topics: Animals; Benzothiazoles; Brain Ischemia; Corpus Striatum; Dopamine Agonists; Dose-Response Relationship, Drug; Gerbillinae; Male; Methamphetamine; Nerve Degeneration; Pramipexole; Substantia Nigra; Thiazoles | 1996 |
D1 dopamine receptor activity of anti-parkinsonian drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Benzothiazoles; Bromocriptine; Cells, Cultured; Cerebellum; Clozapine; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiazoles | 1997 |
Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.
Topics: Adenosine Triphosphate; Animals; Benzothiazoles; Body Temperature; Bromocriptine; Cerebellum; Cyclic GMP; Dopamine Agonists; Male; Motor Activity; Neurons; Neuroprotective Agents; Neurotoxins; Olivary Nucleus; Pramipexole; Pyridines; Rats; Rats, Wistar; Thiazoles | 1997 |
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Injections, Subcutaneous; Levodopa; Male; Mice; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereotyped Behavior; Sulpiride; Thiazoles | 1997 |
Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
Topics: Animals; Antiparkinson Agents; Azepines; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Benzothiazoles; Dopamine Agents; Dopamine Agonists; Drug Interactions; Female; Macaca nemestrina; MPTP Poisoning; Parkinson Disease, Secondary; Pramipexole; Sleep; Thiazoles | 1997 |
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles | 1997 |
Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Cell Count; Cell Survival; Culture Media, Conditioned; Dopamine Agonists; Female; Immunohistochemistry; Levodopa; Mesencephalon; Neurons; Pramipexole; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles; Tyrosine 3-Monooxygenase | 1997 |
Steady-state pharmacokinetic properties of pramipexole in healthy volunteers.
Topics: Adult; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pramipexole; Thiazoles | 1997 |
Involvement of dopamine D2 receptors in the effect of cocaine on sexual behaviour and stretching-yawning of male rats.
Topics: Animals; Benzothiazoles; Cocaine; Copulation; Dopamine Agonists; Dopamine Antagonists; Lisuride; Male; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Sexual Behavior, Animal; Specific Pathogen-Free Organisms; Thiazoles | 1997 |
New dopamine agonists on the horizon.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 1997 |
D3 receptor test in vitro predicts decreased cocaine self-administration in rats.
Topics: Animals; Benzopyrans; Benzothiazoles; Cocaine; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Male; Naphthalenes; Opioid-Related Disorders; Oxazines; Pramipexole; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Self Administration; Thiazoles | 1997 |
Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminoquinolines; Animals; Benzothiazoles; Caudate Nucleus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electrophysiology; Haloperidol; Imidazoles; Neurons; Pramipexole; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Tetrahydronaphthalenes; Thiazoles | 1997 |
Pramipexole marketed for Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Drug Approval; Humans; Parkinson Disease; Pramipexole; Thiazoles; United States; United States Food and Drug Administration | 1997 |
Antidepressant effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antidepressive Agents; Benzothiazoles; Coercion; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Motor Activity; Pramipexole; Rats; Rats, Wistar; Swimming; Thiazoles | 1997 |
Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen.
Topics: Benzothiazoles; Bromocriptine; Cytochrome P-450 Enzyme Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Pergolide; Pramipexole; Thiazoles | 1997 |
Pramipexole and ropinirole for Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 1997 |
Pramipexole for Parkinson's disease.
Topics: Adult; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Humans; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Reproducibility of Results; Thiazoles; Treatment Outcome | 1998 |
Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures.
Topics: Animals; Benzothiazoles; Brain-Derived Neurotrophic Factor; Cells, Cultured; Culture Media, Conditioned; Dopamine; Dopamine Agonists; Glial Cell Line-Derived Neurotrophic Factor; Mesencephalon; Molecular Weight; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Pramipexole; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Thiazoles | 1998 |
Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
Topics: Animals; Behavior, Animal; Benzamides; Benzothiazoles; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Microdialysis; Motor Activity; Neostriatum; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Sleep; Sleep, REM; Thiazoles; Wakefulness | 1998 |
Effect of pramipexole in treatment of resistant restless legs syndrome.
Topics: Adult; Aged; Benzothiazoles; Dopamine Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neurologic Examination; Patient Satisfaction; Polysomnography; Pramipexole; Restless Legs Syndrome; Sleep Stages; Thiazoles; Treatment Outcome | 1998 |
Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Benzothiazoles; Biological Transport; Calcium; Corpus Striatum; Dopamine Agents; Humans; Ion Channel Gating; Liver; Male; Microdialysis; Mitochondria; Neuroblastoma; Neuroprotective Agents; Neurotoxins; Parkinson Disease, Secondary; Phosphorus; Porins; Pramipexole; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured | 1998 |
New anti-parkinsonian drugs.
Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone | 1998 |
[3H](+)-7-OH-DPAT and [3H]pramipexole binding in the striatum and nucleus accumbens of Sprague-Dawley and Fischer-344 rats.
Topics: Animals; Benzothiazoles; Dopamine Agonists; Ligands; Male; Neostriatum; Nucleus Accumbens; Pramipexole; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Thiazoles | 1998 |
Pramipexole has antioxidant properties and inhibits lipid peroxidation.
Topics: Benzothiazoles; Dose-Response Relationship, Drug; Free Radical Scavengers; In Vitro Techniques; Lipid Peroxidation; Photolysis; Pramipexole; Temperature; Thiazoles | 1998 |
Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antiparkinson Agents; Apoptosis; Azepines; Benzothiazoles; Bromocriptine; Bucladesine; Caspase 3; Caspases; Dopamine Agonists; Humans; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Effects of pramipexole on contraversive rotation and functional motor impairments in 1-methyl-4-phenyl1,2,3, 6-tetrahydropyridine-induced chronic hemiparkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agents; Dose-Response Relationship, Drug; Eating; Female; Macaca nemestrina; Motor Activity; Parkinson Disease, Secondary; Pramipexole; Rotation; Stereotyped Behavior; Thiazoles; Volition | 1998 |
Pharmacological approaches to counter the toxicity of Dopa.
Topics: Animals; Benzothiazoles; Cells, Cultured; Cerebellum; Cytoplasmic Granules; Glutathione; Levodopa; Neuroprotective Agents; Pramipexole; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Selegiline; Thiazoles; Vitamin E | 1998 |
Beta-analogs of PLG (L-prolyl-L-leucyl-glycinamide): ex-chiral pool syntheses and dopamine D2 receptor modulating effects.
Topics: Animals; Benzothiazoles; Cattle; Cell Membrane; Dopamine Agonists; In Vitro Techniques; MSH Release-Inhibiting Hormone; Pramipexole; Receptors, Dopamine D2; Thiazoles; Visual Cortex | 1998 |
Weight loss is often a problem in late PD.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Drug Monitoring; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Thiazoles; Weight Gain | 1998 |
Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.
Topics: Animals; Antioxidants; Benzothiazoles; Cell Count; Cell Survival; Cells, Cultured; Culture Media, Conditioned; Dopamine Agents; Dopamine Agonists; Levodopa; Mesencephalon; Neuroprotective Agents; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Tyrosine 3-Monooxygenase; Vitamin E | 1999 |
Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity.
Topics: Animals; Benzothiazoles; Cell Line; Cell Survival; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Glioma; Hybrid Cells; Kinetics; Levodopa; Neuroblastoma; Neuroprotective Agents; Pramipexole; Thiazoles | 1999 |
[3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
Topics: Animals; Benzazepines; Benzothiazoles; Binding, Competitive; Cattle; Corpus Striatum; Dopamine Antagonists; Humans; In Vitro Techniques; Kinetics; Ligands; Membranes; Pramipexole; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Thiazoles | 1999 |
Pramipexole in refractory bipolar depression.
Topics: Adult; Antipsychotic Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles | 1999 |
Cost effectiveness of pramipexole in Parkinson's disease in the US.
Topics: Antiparkinson Agents; Benzothiazoles; Cost-Benefit Analysis; Humans; Parkinson Disease; Pramipexole; Quality-Adjusted Life Years; Sensitivity and Specificity; Thiazoles; United States | 1998 |
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep; Thiazoles; Wakefulness | 1999 |
Restless legs syndrome.
Topics: Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Syndrome; Thiazoles | 1999 |
'Sleep attacks' attributed to new antiparkinsonian drugs.
Topics: Antiparkinson Agents; Benzothiazoles; Humans; Indoles; Narcolepsy; Pramipexole; Thiazoles; United States | 1999 |
[High dosage therapy of Parkinson disease. New dopamine agonist pramipexol allows reduction of L-dopa dose down to zero].
Topics: Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pramipexole; Thiazoles | 1999 |
Several classes of new drugs emerging for Parkinson disease.
Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Thiazoles | 1999 |
Pramipexole treatment for cocaine cravings.
Topics: Adult; Antidepressive Agents; Behavior, Addictive; Benzothiazoles; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Diagnosis, Dual (Psychiatry); Dopamine Agonists; Drug Therapy, Combination; Humans; Lamotrigine; Male; Pramipexole; Thiazoles; Treatment Outcome; Triazines | 1999 |
Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats.
Topics: alpha-Methyltyrosine; Animals; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Electromyography; Haloperidol; Male; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease, Secondary; Pramipexole; Rats; Rats, Wistar; Reserpine; Thiazoles; Treatment Outcome | 1999 |
Acute pediatric exposure to pramipexole dihydrochloride (Mirapex)
Topics: Antiparkinson Agents; Benzothiazoles; Female; Humans; Infant; Pramipexole; Thiazoles | 1999 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzothiazoles; Dopamine; Dopamine Agents; Dopamine Agonists; Free Radical Scavengers; Immunohistochemistry; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Pramipexole; Substantia Nigra; Thiazoles; Thiobarbituric Acid Reactive Substances; Tyrosine 3-Monooxygenase | 2000 |
Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Adenine Nucleotides; Benzothiazoles; Electron Transport; Enzyme Activation; Free Radical Scavengers; Herbicides; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 1; Mitochondria; Mitogen-Activated Protein Kinases; Neuroblastoma; Neurons; NF-kappa B; Oxidative Stress; Parkinson Disease; Peptides; Pramipexole; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-raf; Signal Transduction; Superoxide Dismutase; Thiazoles; Tumor Cells, Cultured | 2000 |
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.
Topics: Benzothiazoles; Chronic Disease; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Middle Aged; Pramipexole; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazoles | 2000 |
Pleural fibrosis associated with dihydroergocryptine treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cough; Dopamine Agonists; Dyspnea; Ergolines; Humans; Male; Parkinson Disease; Pramipexole; Pulmonary Fibrosis; Thiazoles | 2000 |
Clinical characteristics of pramipexole-induced peripheral edema.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Edema; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Peripheral Nervous System Diseases; Pramipexole; Retrospective Studies; Severity of Illness Index; Thiazoles | 2000 |
Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine.
Topics: Animals; Benzothiazoles; Cell Count; Cell Death; Dopamine; Dopamine Agonists; Male; Neostriatum; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Pramipexole; Rats; Rats, Sprague-Dawley; Substantia Nigra; Thiazoles | 2000 |
Non-ergot dopamine agonist-induced sleep attacks.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Thiazoles | 2000 |
Increase of bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole.
Topics: Animals; Antiparkinson Agents; Azepines; Benzothiazoles; Cell Membrane; Cerebral Cortex; Cytosol; Dendrites; Dopamine Agonists; Drug Administration Schedule; Hippocampus; Immunoblotting; Injections, Intraperitoneal; Male; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Thiazoles | 2000 |
Sleep episodes in Parkinson's disease: a wake-up call.
Topics: Accidents, Traffic; Antiparkinson Agents; Benzothiazoles; Humans; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
Pramipexole and somnolence.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Male; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
Topics: Adult; Benzothiazoles; Bipolar Disorder; Depressive Disorder; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2000 |
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Hypotension, Orthostatic; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Thiazoles | 2000 |
Pramipexole is a possible effective treatment for primary orthostatic tremor (shaky leg syndrome).
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Evidence-Based Medicine; Humans; Hypotension, Orthostatic; Leg; Male; Pramipexole; Severity of Illness Index; Thiazoles; Treatment Outcome; Tremor | 2000 |
Dopamine agonists in early therapy for Parkinson disease: promise and problems.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study.
Topics: Adrenergic Agents; Animals; Benzothiazoles; Corpus Striatum; Dopamine; Dopamine Agonists; Hydroxybenzoates; Hydroxyl Radical; Male; Microdialysis; Oxidopamine; Pergolide; Pramipexole; Rats; Rats, Wistar; Thiazoles | 2000 |
Safety of pramipexole in patients with restless legs syndrome.
Topics: Aged; Benzothiazoles; Female; Humans; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Thiazoles | 2000 |
Modafinil treatment of pramipexole-associated somnolence.
Topics: Adult; Antiparkinson Agents; Benzhydryl Compounds; Benzothiazoles; Central Nervous System Stimulants; Drug Therapy, Combination; Female; Humans; Modafinil; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome | 2000 |
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles | 2000 |
Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection.
Topics: Animals; Antioxidants; Benzothiazoles; Cell Line; Cell Survival; Dopamine; Dopamine D2 Receptor Antagonists; Hydrogen Peroxide; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Pramipexole; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles | 2000 |
[Dopaminergic agonists in the treatment of Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles | 2000 |
Pramipexole augmentation in panic with agoraphobia.
Topics: Adult; Agoraphobia; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Panic Disorder; Pramipexole; Psychotropic Drugs; Receptors, Dopamine D2; Thiazoles; Treatment Outcome | 2001 |
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cabergoline; Disorders of Excessive Somnolence; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies; Thiazoles | 2001 |
Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Antiparkinson Agents; Azepines; Benzothiazoles; Caspases; Cell-Free System; Cytochrome c Group; Cytosol; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Nerve Tissue Proteins; Organelles; Pramipexole; Synucleins; Thiazoles; Tumor Cells, Cultured | 2001 |
Antiparkinsonian drugs and "sleep attacks".
Topics: Adverse Drug Reaction Reporting Systems; Aged; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Canada; Humans; Indoles; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Thiazoles | 2001 |
Neuroprotective effects of pramipexole in young and aged MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Antiparkinson Agents; Benzothiazoles; Cell Survival; Dopamine; Dopamine Agents; Fluorescent Dyes; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neostriatum; Neural Pathways; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Pramipexole; Stilbamidines; Substantia Nigra; Thiazoles; Tyrosine 3-Monooxygenase | 2001 |
The effect of repeated treatment with pramipexole on the central dopamine D3 system.
Topics: Animals; Benzothiazoles; Brain; Dopamine Agonists; In Situ Hybridization; Male; Motor Activity; Nucleus Accumbens; Pramipexole; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; RNA, Messenger; Tetrahydronaphthalenes; Thiazoles; Transcription, Genetic; Tritium | 2000 |
Current advances in Parkinson's disease.
Topics: Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Brain Stem; Catechols; Depression; Dopamine Agonists; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles | 2001 |
Modafinil and pramipexole-associated somnolence.
Topics: Antiparkinson Agents; Benzhydryl Compounds; Benzothiazoles; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Modafinil; Parkinsonian Disorders; Pramipexole; Thiazoles; Treatment Outcome | 2001 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Pramipexole for depression.
Topics: Adult; Antidepressive Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pramipexole; Thiazoles; Treatment Outcome | 2002 |
Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma.
Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Amyloid beta-Peptides; Anti-Bacterial Agents; Aristolochic Acids; Benzothiazoles; Bongkrekic Acid; Brain; Caspase Inhibitors; Caspases; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Humans; Neuroblastoma; Neurodegenerative Diseases; Neurons; Parkinson Disease; Peptide Fragments; Phenanthrenes; Pramipexole; Thiazoles; Tumor Cells, Cultured | 2002 |
Alopecia induced by dopamine agonists.
Topics: Aged; Alopecia; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 2002 |
Influence of sildenafil on copulatory behaviour in sluggish or normal ejaculator male rats: a central dopamine mediated effect?
Topics: Animals; Benzothiazoles; Copulation; Dopamine Agonists; Ejaculation; Female; Male; Phosphodiesterase Inhibitors; Piperazines; Pramipexole; Purines; Rats; Rats, Wistar; Salicylamides; Sildenafil Citrate; Sulfones; Thiazoles | 2002 |
[Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved].
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Depressive Disorder; Dopamine Agonists; Humans; Multicenter Studies as Topic; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome; Tremor | 2002 |
A case of Parkinsonism due to lithium intoxication: treatment with Pramipexole.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Humans; Lithium; Parkinsonian Disorders; Pramipexole; Severity of Illness Index; Thiazoles | 2002 |
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.
Topics: Antiparkinson Agents; Benzothiazoles; Brain; Cocaine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2002 |
Effect of daily dosing duration of direct and indirect dopamine receptor agonists: cocaine cross-tolerance following chronic regimens.
Topics: Analysis of Variance; Animals; Area Under Curve; Autoreceptors; Benzothiazoles; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Dopamine Agonists; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Male; Motor Activity; Piperazines; Pramipexole; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Thiazoles; Time Factors | 2002 |
[Pramipexole in Parkinson disease. Results of a treatment observation].
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Female; Humans; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pramipexole; Product Surveillance, Postmarketing; Receptors, Dopamine D2; Thiazoles; Treatment Outcome | 2002 |
Potential antidepressant properties of pramipexole detected in locomotor and operant behavioral investigations in mice.
Topics: Animals; Antidepressive Agents; Benzothiazoles; Conditioning, Operant; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred Strains; Motor Activity; Pramipexole; Reinforcement Schedule; Reinforcement, Psychology; Thiazoles; Time Factors | 2002 |
A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist.
Topics: Animals; Benzothiazoles; Cerebrovascular Circulation; Dopamine; Dopamine Agonists; Limbic System; Mental Disorders; Mood Disorders; Papio; Pramipexole; Prefrontal Cortex; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Tomography, Emission-Computed | 2002 |
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics.
Topics: Antiparkinson Agents; Area Under Curve; Benzothiazoles; Biological Availability; Body Weight; Drug Interactions; Female; Humans; Levodopa; Male; Pramipexole; Sex Characteristics; Thiazoles | 2002 |
Sleepwalking and sleep terrors in prepubertal children: what triggers them?
Topics: Benzothiazoles; Child; Child, Preschool; Electroencephalography; Female; Follow-Up Studies; Humans; Infant; Male; Night Terrors; Parasomnias; Polysomnography; Pramipexole; Retrospective Studies; Sleep Apnea Syndromes; Somnambulism; Thiazoles | 2003 |
Loss of color vision during long-term treatment with pramipexole.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Color Vision Defects; Humans; Male; Parkinson Disease; Pramipexole; Thiazoles; Time Factors | 2003 |
Multiple blood donations associated with iron deficiency in patients with restless legs syndrome.
Topics: Adult; Anemia, Iron-Deficiency; Antioxidants; Benzothiazoles; Blood Donors; Female; Ferritins; Follow-Up Studies; Hemoglobins; Humans; Iron Compounds; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Thiazoles; Treatment Outcome | 2003 |
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Caudate Nucleus; Cocaine; Corpus Striatum; Disease Progression; Female; Humans; Male; Nerve Degeneration; Parkinson Disease; Pergolide; Pramipexole; Putamen; Radiopharmaceuticals; Receptors, Dopamine D2; Reproducibility of Results; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2003 |
The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa.
Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles | 2003 |
The use of dopamine enhancing medications with children in low response states following brain injury.
Topics: Adolescent; Adult; Amantadine; Arousal; Awareness; Benzothiazoles; Brain Injuries; Bromocriptine; Child; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Methylphenidate; Neuropsychological Tests; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome; Unconsciousness | 2003 |
REAL and CALM: what have we learned?
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression; Dopamine; Feasibility Studies; Humans; Indoles; Levodopa; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Putamen; Reference Values; Sensitivity and Specificity; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Recurrence; Retrospective Studies; Suicide; Thiazoles | 2003 |
Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration.
Topics: Animals; Benzothiazoles; Corpus Striatum; Dopamine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Degeneration; Neuropeptides; Parkinson Disease; Pramipexole; Rats; Rats, Sprague-Dawley; Synaptic Vesicles; Thiazoles; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
[Treatment of restless legs syndrome in uremic patients undergoing dialysis with pramipexole: preliminary results].
Topics: Benzothiazoles; Dopamine Agonists; Humans; Pramipexole; Renal Dialysis; Restless Legs Syndrome; Severity of Illness Index; Thiazoles; Uremia | 2003 |
Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms.
Topics: Animals; Benzothiazoles; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MPTP Poisoning; Piperazines; Pramipexole; Pyrimidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles | 2003 |
Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Behavior, Animal; Benzothiazoles; Binding, Competitive; Corpus Striatum; Disease Models, Animal; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Neuropeptides; Oxidopamine; Parkinsonian Disorders; Pramipexole; Rats; Rats, Sprague-Dawley; Substantia Nigra; Thiazoles; Treatment Outcome; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Benzothiazoles; Clinical Trials, Phase III as Topic; Female; Humans; Male; Middle Aged; Muscle Rigidity; Observation; Parkinson Disease; Pramipexole; Prospective Studies; Statistics, Nonparametric; Thiazoles | 2003 |
Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole.
Topics: Adenylyl Cyclases; Animals; Antiparkinson Agents; Benzothiazoles; Binding, Competitive; Colforsin; COS Cells; Dimerization; Enzyme Activation; Humans; Indoles; Ligands; Nucleus Accumbens; Oxazines; Pertussis Toxin; Pramipexole; Protein Binding; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Transfection | 2003 |
Oral anticoagulation for ECG tremor artefact simulating atrial fibrillation.
Topics: Aged; Anticoagulants; Antiparkinson Agents; Atrial Fibrillation; Benzothiazoles; Diagnosis, Differential; Diagnostic Errors; Electrocardiography; Female; Humans; Parkinson Disease; Phenprocoumon; Pramipexole; Thiazoles | 2003 |
Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Benzothiazoles; Cell Count; Cell Line; DNA; Dopamine Agents; Dopamine Agonists; Humans; Immunohistochemistry; Indoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrazolium Salts; Thiazoles | 2003 |
Pramipexole in Restless Legs syndrome. Evaluation by suggested immobilization test.
Topics: Benzothiazoles; Dopamine Agonists; Female; Humans; Immobilization; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Thiazoles | 2003 |
Fibromyalgia and pramipexole: promise and precaution.
Topics: Benzothiazoles; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Fibromyalgia; Humans; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome | 2003 |
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness | 2004 |
Slowing Parkinson's disease progression: recent dopamine agonist trials.
Topics: Antiparkinson Agents; Artifacts; Benzothiazoles; Clinical Trials as Topic; Disease Progression; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Severity of Illness Index; Single-Blind Method; Thiazoles | 2004 |
Slowing Parkinson's disease progression: recent dopamine agonist trials.
Topics: Antiparkinson Agents; Benzothiazoles; Biological Transport; Cell Line, Tumor; Clinical Trials as Topic; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Indoles; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroblastoma; Parkinson Disease; Pramipexole; Thiazoles | 2004 |
The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
Topics: Animals; Benzothiazoles; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Male; Mice; Mice, Knockout; Motor Activity; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Species Specificity; Swimming; Thiazoles | 2004 |
Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis.
Topics: Adult; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pramipexole; Renal Dialysis; Restless Legs Syndrome; Thiazoles; Uremia | 2004 |
The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia.
Topics: Animals; Benzazepines; Benzothiazoles; Cebus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Indoles; Male; Nitriles; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydroisoquinolines; Thiazoles | 2004 |
Pramipexole-treated Parkinson's disease during pregnancy.
Topics: Adult; Benzothiazoles; Dopamine Agonists; Female; Humans; Parkinson Disease; Pramipexole; Pregnancy; Pregnancy Complications; Severity of Illness Index; Thiazoles | 2004 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
Predictors of sudden onset of sleep in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Comorbidity; Cross-Sectional Studies; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pramipexole; Risk Factors; Surveys and Questionnaires; Thiazoles | 2004 |
Calming restless legs.
Topics: Analgesics, Opioid; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Indoles; Nocturnal Myoclonus Syndrome; Pramipexole; Restless Legs Syndrome; Thiazoles; Wakefulness | 2004 |
Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Down-Regulation; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Fibers; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Receptors, Dopamine D3; Thiazoles | 2004 |
Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antibodies; Benzothiazoles; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Line; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetradecanoylphorbol Acetate; Thiazoles; Tretinoin | 2004 |
Periodic leg movements in prepubertal children with sleep disturbance.
Topics: Benzothiazoles; Brain; Child; Child, Preschool; Comorbidity; Diagnosis, Differential; Disorders of Excessive Somnolence; Dopamine Agonists; Fatigue Syndrome, Chronic; Female; Follow-Up Studies; Humans; Infant; Male; Mental Disorders; Nocturnal Myoclonus Syndrome; Polysomnography; Pramipexole; Prevalence; Prospective Studies; Severity of Illness Index; Thiazoles | 2004 |
[Pramipexole for intractable hiccups].
Topics: Aged; Aged, 80 and over; Benzothiazoles; Hiccup; Humans; Male; Pramipexole; Thiazoles | 2004 |
Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Antioxidants; Benzothiazoles; Carbocyanines; Caspase 3; Caspases; Cell Count; Cell Death; Cell Line, Tumor; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Drug Interactions; Flow Cytometry; Humans; Jurkat Cells; L-Lactate Dehydrogenase; Mitochondria; Necrosis; Neuroblastoma; Pramipexole; Rotenone; Thiazoles | 2004 |
Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney.
Topics: Amantadine; Animals; Benzothiazoles; Corticosterone; Female; In Vitro Techniques; Kidney; Kidney Tubules, Proximal; Male; Oocytes; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Pramipexole; Procainamide; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Thiazoles; Xenopus laevis | 2005 |
Molecular studies probe bipolar disorder.
Topics: Animals; Benzothiazoles; Bipolar Disorder; Carrier Proteins; Central Nervous System Agents; DNA-Binding Proteins; Gene Expression Regulation; Genes, bcl-2; Humans; Lithium Carbonate; Neuronal Plasticity; Pramipexole; Signal Transduction; Thiazoles; Transcription Factors; Valproic Acid | 2005 |
Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection.
Topics: Benzothiazoles; Cell Line, Tumor; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Pramipexole; Thiazoles | 2005 |
"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.
Topics: Aged; Amantadine; Benzothiazoles; Catechols; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Iatrogenic Disease; Indoles; Levodopa; Male; Middle Aged; Neurology; Neuropharmacology; Neurotoxicity Syndromes; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles; Treatment Outcome | 2005 |
Pramipexole, ropinirole, and mania in Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2005 |
Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.
Topics: Anti-Bacterial Agents; Antiparkinson Agents; Benzothiazoles; Brain; Chronic Disease; Dipeptides; Evoked Potentials, Visual; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Paromomycin; Pramipexole; Recovery of Function; Thiazoles; Treatment Outcome; Vision Disorders | 2005 |
Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antiparkinson Agents; Benzoquinones; Benzothiazoles; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Electron Spin Resonance Spectroscopy; Functional Laterality; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine; Parkinson Disease; Pramipexole; Thiazoles; Time Factors | 2005 |
Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Humans; Lung; Male; Molecular Structure; Parkinson Disease; Pergolide; Pleura; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Thiazoles; Tomography, X-Ray Computed | 2005 |
Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
Topics: Animals; Benzothiazoles; Binding, Competitive; Brain; Cells, Cultured; Cricetinae; Domperidone; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Mice; Neurons; Oxazines; Parkinson Disease; Pramipexole; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Synapses; Synaptic Transmission; Thiazoles; Tritium | 2005 |
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Catechols; Databases, Factual; Dopamine Agonists; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Multiple System Atrophy; Nitriles; Parkinson Disease; Pramipexole; Sexual Dysfunctions, Psychological; Thiazoles | 2005 |
[Syndrome of inappropriate ADH secretion (SIADH) induced by pramipexole in a patient with Parkinson's disease].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Female; Humans; Parkinson Disease; Pituitary ACTH Hypersecretion; Pramipexole; Thiazoles | 2005 |
Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.
Topics: Animals; Benzothiazoles; Binding Sites; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Crystallography, X-Ray; Cyclohexanes; Dopamine Agonists; Humans; Hydrogen Bonding; In Vitro Techniques; Mitosis; Models, Molecular; Molecular Structure; Pramipexole; Pyrazoles; Pyridines; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship; Swine; Thiazoles | 2005 |
Pathological gambling in Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Brain; Dopamine Agonists; Dose-Response Relationship, Drug; Gambling; Humans; Indoles; Mental Disorders; Neural Pathways; Parkinson Disease; Pramipexole; Thiazoles | 2005 |
Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride].
Topics: Aconitate Hydratase; Animals; Antioxidants; Astrocytes; Benzothiazoles; Brain Chemistry; Cell Line, Tumor; Cerebellum; Culture Media; Dopamine Agonists; Hydrogen Peroxide; Hyperkinesis; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Motor Activity; Neuroprotective Agents; Oxidants; Pramipexole; Stereoisomerism; Superoxide Dismutase; Superoxide Dismutase-1; Thiazoles | 2006 |
Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons.
Topics: Animals; Astrocytes; Benzothiazoles; Blotting, Western; Brain-Derived Neurotrophic Factor; Cell Count; Cells, Cultured; Culture Media, Conditioned; Dopamine; Dopamine Agonists; Enzyme-Linked Immunosorbent Assay; Female; Glial Cell Line-Derived Neurotrophic Factor; Immunohistochemistry; Indoles; Mesencephalon; Neurons; Pramipexole; Pregnancy; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Tyrosine 3-Monooxygenase | 2005 |
The neurophysiology of the alternating leg muscle activation (ALMA) during sleep: study of one patient before and after treatment with pramipexole.
Topics: Adult; Benzothiazoles; Dopamine Agonists; Electroencephalography; Electromyography; Humans; Leg; Male; Muscle, Skeletal; Nocturnal Myoclonus Syndrome; Pramipexole; Restless Legs Syndrome; Severity of Illness Index; Sleep Stages; Surveys and Questionnaires; Thiazoles | 2006 |
Pramipexole protects against H2O2-induced PC12 cell death.
Topics: Animals; Antiparkinson Agents; Apoptosis; Benzothiazoles; Caspase 3; Caspases; Cell Death; Cell Survival; Cytochromes c; Dopamine Agonists; Dopamine Antagonists; Hydrogen Peroxide; L-Lactate Dehydrogenase; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Pramipexole; Rats; Thiazoles | 2006 |
Patch clamp reveals powerful blockade of the mitochondrial permeability transition pore by the D2-receptor agonist pramipexole.
Topics: Animals; Apoptosis; Benzothiazoles; Calcium; Dopamine; Ion Channels; Lipid Peroxidation; Male; Membrane Potentials; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Patch-Clamp Techniques; Pramipexole; Rats; Rats, Wistar; Thiazoles | 2006 |
Parkinson's drug may relieve fibromyalgia pain.
Topics: Antiparkinson Agents; Benzothiazoles; Fibromyalgia; Humans; Pain; Pramipexole; Thiazoles | 2005 |
Pramipexole protects against MPTP toxicity in non-human primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antioxidants; Benzothiazoles; Callithrix; Cell Count; Corpus Striatum; Disease Models, Animal; Drug Administration Schedule; Female; Immunohistochemistry; Male; MPTP Poisoning; Pramipexole; Thiazoles; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
Gambling and Parkinson disease.
Topics: Antiparkinson Agents; Benzothiazoles; Gambling; Humans; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Thiazoles | 2006 |
Hiccups associated with dopamine agonists in Parkinson disease.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Hiccup; Humans; Male; Parkinson Disease; Pergolide; Pramipexole; Thiazoles | 2006 |
Restless legs syndrome: facts & treatments. This strange malady affects 12 million Americans, many of whom go misdiagnosed or undiagnosed.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Pramipexole; Restless Legs Syndrome; Thiazoles | 2006 |
Pramipexole: augmentation in the treatment of depressive symptoms.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Pramipexole; Somatoform Disorders; Thiazoles | 2006 |
Validated chiral liquid chromatographic method for the enantiomeric separation of Pramipexole dihydrochloride monohydrate.
Topics: Antiparkinson Agents; Benzothiazoles; Chromatography, Liquid; Dopamine Agonists; Pramipexole; Reproducibility of Results; Stereoisomerism; Thiazoles | 2006 |
Chronic cluster headache responsive to pramipexole.
Topics: Antiparkinson Agents; Benzothiazoles; Cluster Headache; Dopamine Agonists; Humans; Incidental Findings; Male; Middle Aged; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome | 2006 |
Reversal learning in Parkinson's disease depends on medication status and outcome valence.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Female; Humans; Learning Disabilities; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Reversal Learning; Thiazoles | 2006 |
[Restless legs syndrome: when uncontrollable urge to move afflicts the patient...].
Topics: Adult; Age Factors; Benzothiazoles; Clinical Trials as Topic; Diagnosis, Differential; Dopamine Agonists; Female; Humans; Male; Middle Aged; Placebos; Pramipexole; Pregnancy; Restless Legs Syndrome; Sex Factors; Thiazoles; Time Factors | 2006 |
Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Follow-Up Studies; Gambling; Humans; Indoles; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Thiazoles | 2006 |
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease].
Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome | 2006 |
[Dopamine agonists for treatment of restless leg syndrome].
Topics: Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Pramipexole; Restless Legs Syndrome; Thiazoles | 2006 |
[Case of juvenile parkinsonism in pregnancy].
Topics: Adult; Antiparkinson Agents; Benzothiazoles; Cabergoline; Carbidopa; Contraindications; Dopamine Agents; Dopamine Agonists; Ergolines; Family Planning Services; Female; Humans; Infant, Newborn; Levodopa; Parkinsonian Disorders; Pramipexole; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thiazoles | 2006 |
Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells.
Topics: Animals; Apoptosis; Benzothiazoles; Cell Death; Dopamine Agonists; Dopamine Antagonists; Endoplasmic Reticulum; L-Lactate Dehydrogenase; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Pramipexole; Rats; Spiperone; Tetrazolium Salts; Thiazoles; Tunicamycin | 2009 |
Pramipexole associated dystonia.
Topics: Benzothiazoles; Dopamine Agonists; Dystonia; Dystonic Disorders; Humans; Parkinson Disease; Pramipexole; Thiazoles | 2017 |